400
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary Infections

, ORCID Icon, , , , , , , , , & show all
Pages 2535-2553 | Published online: 02 Jun 2022

References

  • Limbert M, Isert D, Klesel N, et al. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1991;35(1):14–19. doi:10.1128/AAC.35.1.14
  • Parlevliet JM, Lynn JW, Paccamonti DL. The use of cefquinome in equine semen extender. J Equine Vet Sci. 2011;31(3):139–142. doi:10.1016/j.jevs.2010.12.015
  • Zhou YF, Zhao DH, Yu Y, et al. Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs. J Vet Pharmacol Ther. 2015;38(6):543–548. doi:10.1111/jvp.12225
  • Thomas E, Thomas V, Wilhelm C. Antibacterial activity of cefquinome against equine bacterial pathogens. Vet Microbiol. 2006;115(1–3):140–147. doi:10.1016/j.vetmic.2005.12.019
  • Lee DH, Birhanu BT, Lee EB, et al. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. Equi in Foals Vet Res. 2020;51(1):131. doi:10.1186/s13567-020-00853-2
  • Funaki H, Uzuka Y, Tanabe S, et al. Therapeutic efficacy of cefquinome against acute respiratory disease in holstein steers. J Jpn Vet Med Assoc. 2001;54:451–454. doi:10.12935/jvma1951.54.451
  • Khusro A, Aarti C, Buendía-Rodriguez G, Arasu MV, Al-Dhabi NA, Barbabosa-Pliego A. Adverse effect of antibiotics administration on horse health: an overview. J Equine Vet Sci. 2021;97:103339. doi:10.1016/j.jevs.2020.103339
  • Ahmad I, Hao H, Huang L, et al. Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle. Front Microbiol. 2015;6:588. doi:10.3389/fmicb.2015.00588
  • Fu Q, Fu HL, Huan L, et al. Preparation of cefquinome sulfate proliposome and its pharmacokinetics in rabbit. Iran J Pharm Res. 2013;12(4):611–621.
  • Zhang S, Dai W, Lu Z, et al. Preparation and evaluation of cefquinome-loaded gelatin microspheres and the pharmacokinetics in pigs. J Vet Pharmacol Ther. 2018;41(1):117–124. doi:10.1111/jvp.12429
  • Du X, Zu S, Chen F, et al. Preparation and characterization of cefquinome sulfate microparticles for transdermal delivery by negative-pressure cavitation antisolvent precipitation. Powder Technol. 2016;294:429–436. doi:10.1016/j.powtec.2016.03.008
  • Kesisoglou F, Panmai S, Wu Y. Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59(7):631–644. doi:10.1016/j.addr.2007.05.003
  • Sinha B, Müller RH, Möschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm. 2013;453(1):126–141. doi:10.1016/j.ijpharm.2013.01.019
  • Lu Y, Li Y, Wu W. Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B. 2016;6(2):106–113. doi:10.1016/j.apsb.2015.11.005
  • Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm. 2011;409(1–2):260–268. doi:10.1016/j.ijpharm.2011.02.051
  • Mallappa MK, Kesarla R, Banakar S. Calcium Alginate-Neusilin US2 nanocomposite microbeads for oral sustained drug delivery of poor water soluble drug aceclofenac sodium. J Drug Deliv. 2015;2015:826981. doi:10.1155/2015/826981
  • Yadava SK, Basu SM, Chauhan M, et al. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application. Colloids Surf B Biointerfaces. 2020;190:110927. doi:10.1016/j.colsurfb.2020.110927
  • McCartney F, Jannin V, Chevrier S, et al. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies. J Controlled Release. 2019;310:115–126. doi:10.1016/j.jconrel.2019.08.008
  • Balakrishnan P, Lee B-J, Oh DH, et al. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm. 2009;374(1):66–72. doi:10.1016/j.ijpharm.2009.03.008
  • Oh DH, Kang JH, Kim DW, et al. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 2011;420(2):412–418. doi:10.1016/j.ijpharm.2011.09.007
  • Li X, Wu W, Su D, Wang Z, Jiang H, Shen J. Pharmacokinetics and bioavailability of cefquinome in healthy piglets. J Vet Pharmacol Ther. 2008;31(6):523–527. doi:10.1111/j.1365-2885.2008.00989.x
  • Das A, Nayak AK, Mohanty B, Panda S. Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers. ISRN Pharm. 2011;2011:819765. doi:10.5402/2011/819765
  • Guo T, Zhang Y, Zhao J, Zhu C, Feng N. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum. J Nanobiotechnology. 2015;13:47. doi:10.1186/s12951-015-0107-3
  • Bunaciu AA, Udriştioiu EG, Aboul-Enein HY. X-ray diffraction: instrumentation and applications. Crit Rev Anal Chem. 2015;45(4):289–299. doi:10.1080/10408347.2014.949616
  • Yadav PS, Yadav E, Verma A, Amin S. Development, characterization, and pharmacodynamic evaluation of hydrochlorothiazide loaded self-nanoemulsifying drug delivery systems. Sci World J. 2014;2014:274823. doi:10.1155/2014/274823
  • Cilurzo F, Selmin F, Minghetti P, et al. Injectability evaluation: an open issue. AAPS Pharm Sci Tech. 2011;12(2):604–609. doi:10.1208/s12249-011-9625-y
  • Palur K, Archakam SC, Lingasani N, Diviti R, Komarla Kumarachari R, Velusamy S. RP-HPLC method for the estimation of ceftiofur hydrochloride in bulk form. J Pharm Res. 2013;7(3):246–251.
  • National Pharmacopoeia Commission. Chinese Pharmacopoeia [M]. Beijing: China Pharmaceutical Science and Technology Press; 2020:1088.
  • Ahsan T, Chen J, Zhao X, Irfan M, Wu Y. Extraction and identification of bioactive compounds (eicosane and dibutyl phthalate) produced by Streptomyces strain KX852460 for the biological control of Rhizoctonia solani AG-3 strain KX852461 to control target spot disease in tobacco leaf. AMB Express. 2017;7(1):54. doi:10.1186/s13568-017-0351-z
  • Cao J, Huang J, Gui S, Chu X. Preparation, synergism, and biocompatibility of in situ liquid crystals loaded with sinomenine and 5-Fluorouracil for treatment of liver cancer. Int J Nanomedicine. 2021;16:3725–3739. doi:10.2147/IJN.S207607
  • Dou JP, Wu Q, Fu CH, et al. Amplified intracellular Ca (2+) for synergistic anti-tumor therapy of microwave ablation and chemotherapy. J Nanobiotechnology. 2019;17(1):118. doi:10.1186/s12951-019-0549-0
  • Tan X, Gao P, Li Y, et al. Poly-dopamine, poly-levodopa, and poly-norepinephrine coatings: comparison of physico-chemical and biological properties with focus on the application for blood-contacting devices. Bioact Mater. 2021;6(1):285–296. doi:10.1016/j.bioactmat.2020.06.024
  • Tao Y, Yang F, Meng K, et al. Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig. Drug Deliv. 2019;26(1):273–280. doi:10.1080/10717544.2019.1580798
  • Mazutti da Silva SM, Rezende Costa CR, Martins Gelfuso G, et al. Wound healing effect of essential oil extracted from Eugenia dysenterica DC (Myrtaceae) leaves. Molecules. 2018;24(1):2. doi:10.3390/molecules24010002
  • Shan Q, Liang C, Wang J, Li J, Zeng Z. In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice. Antimicrob Agents Chemother. 2014;58(10):5943–5946. doi:10.1128/AAC.03446-14
  • Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–947. doi:10.2147/IJN.S121881
  • Elazab ST, Schrunk DE, Griffith RW, et al. Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits. J Vet Pharmacol Ther. 2018;41(3):374–377. doi:10.1111/jvp.12489
  • Zhan H, Yang X, Wang C, Liang C, Wu M. Multiple growth stages and their kinetic models of anatase nanoparticles under hydrothermal conditions. J Phys Chem C. 2010;114(34):14461–14466. doi:10.1021/jp1062308
  • Pasaribu KM, Gea S, Ilyas S, et al. Fabrication and in-vivo study of micro-colloidal Zanthoxylum acanthopodium-loaded bacterial cellulose as a burn wound dressing. Polymers. 2020;12(7):1436. doi:10.3390/polym12071436
  • Tran T, Xi X, Rades T, Müllertz A. Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine. Int J Pharm. 2016;502(1–2):151–160. doi:10.1016/j.ijpharm.2016.02.026
  • Milović M, Simović S, Lošić D, Dashevskiy A, Ibrić S. Solid self-emulsifying phospholipid suspension (SSEPS) with diatom as a drug carrier. Eur J Pharm Sci. 2014;63:226–232. doi:10.1016/j.ejps.2014.07.010
  • Archana K, Aman A, Jabeen A. Effect of superfine grinding on structural, morphological and antioxidant properties of ginger (Zingiberofficinale) nano crystalline food powder. Mater Today. 2021;43:3397–3403.
  • Xie S, Zhang X, Luo W, et al. Formulation, characterization and pharmacokinetics of long-acting ceftiofur hydrochloride suspension. Curr Drug Deliv. 2021;18(2):224–233. doi:10.2174/1567201817666200903165119
  • Wang T, Shen L, Zhang Y, Li H, Wang Y, Quan D. “Oil-soluble” reversed lipid nanoparticles for oral insulin delivery. J Nanobiotechnology. 2020;18(1):1–11. doi:10.1186/s12951-020-00657-8
  • Fatimi A, Tassin J-F, Axelos MA, Weiss P. The stability mechanisms of an injectable calcium phosphate ceramic suspension. J Mater Sci. 2010;21(6):1799–1809. doi:10.1007/s10856-010-4047-z
  • Ogaji JI, Omachi JA, Iranloye TA. Effect of Adansonia digitata gum on some physicochemical properties of paracetamol pediatric suspension formulations. Int J Res Pharm Sci. 2012;2(2):129–141.
  • Wang B, Xinbiao Y, Jianying C. The method for improving the dissolution rate of cefquinome sulfate and its dissolution test method: CN111714501A[P]; 2020.